Product Information
REMICADE 100 MG VIAL is a brand product labeled by Janssen Biotech, Inc., priced at $1135.9660 per EA under NDC 57894003001. Its NADAC has been published 274 times since Nov 28, 2013.
Strength
100 mg/10mL
Manufacturer
Janssen Biotech, Inc.NDC
57894003001
Classification
Brand
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Last Updated
3/19/2025
Active Ingredients
INFLIXIMABApproval Type
Biologic (BLA)
FDA Application
BLA103772On Market Since
8/24/1998
Pharmacological Classes
Price Statistics
The NADAC for REMICADE 100 MG VIAL has been published 274 times since Nov 28, 2013, and over the history we have for it it has risen 40.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1135.9660 per EA |
|---|---|
| All-time high | $1135.9900 (Dec 11, 2024) |
| All-time low | $809.1313 (Nov 28, 2013) |
| 52-week high | $1135.9660 |
| 52-week low | $1135.9660 |
| Median price | $1130.5883 |
| Average price | $1038.5158 |
| Largest weekly change | +11.1% (Aug 17, 2016) |
| Weeks tracked | 274 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the INFLIXIMAB market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of REMICADE 100 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for REMICADE 100 MG VIAL, manufactured by Janssen Biotech, Inc., is $1135.9660 per EA (NDC 57894003001), effective Mar 11, 2026.
How has the price of REMICADE 100 MG VIAL changed over time?
Over the history we have for it, the NADAC for REMICADE 100 MG VIAL has risen 40.4%. It has been tracked across 274 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for REMICADE 100 MG VIAL?
Since Nov 28, 2013, the NADAC for REMICADE 100 MG VIAL has ranged from a low of $809.1313 (Nov 28, 2013) to a high of $1135.9900 (Dec 11, 2024), with a median of $1130.5883 per EA.
Are there cheaper alternatives to REMICADE 100 MG VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of REMICADE 100 MG VIAL, so no direct lower-cost alternative is listed.
Who manufactures REMICADE 100 MG VIAL?
REMICADE 100 MG VIAL (NDC 57894003001) is labeled by Janssen Biotech, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification